MiCo BioMed Co., Ltd.

A214610

KR7214610008

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
1,387 ^KRW	+1.24%		-4.01%	-25.11%

2023	MiCo BioMed Co., Ltd.(KOSDAQ:A214610) dropped from S&P Global BMI Index	CI
2023	Miko Co., Ltd. entered a stock purchase contract to acquire an additional 2.77% stake in MiCo BioMed Co., Ltd. from KoMiCo Ltd. for KRW 2.6 billion.	CI

Nanobiosys Inc. authorizes a Buyback Plan.

August 30, 2017

The Board of Directors of Nanobiosys Inc. has authorized a buyback plan on August 31, 2017.

Latest news about MiCo BioMed Co., Ltd.

MiCo BioMed Co., Ltd.(KOSDAQ:A214610) dropped from S&P Global BMI Index	18/09/23	CI
Miko Co., Ltd. entered a stock purchase contract to acquire an additional 2.77% stake in MiCo BioMed Co., Ltd. from KoMiCo Ltd. for KRW 2.6 billion.	01/06/23	CI
MiCo BioMed Co., Ltd. announced that it has received KRW 9 billion in funding	17/10/22	CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 9 billion in funding	13/10/22	CI
MiCo BioMed Co., Ltd. announced that it has received KRW 20 billion in funding	05/12/21	CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 20 billion in funding	28/11/21	CI
MiCo BioMed Co., Ltd.(KOSDAQ:A214610) added to S&P Global BMI Index	20/09/21	CI
Speclipse, Inc. announced that it has received $7.7 million in funding from S'ignite Partners Co., Ltd., BNH Investment LLC, Shinhan Capital Co., Ltd., MiCo Ltd., MiCo BioMed Co., Ltd.	18/08/21	CI
MiCo BioMed Co., Ltd. announced that it has received KRW 5 billion in funding	27/10/19	CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 5 billion in funding	13/10/19	CI
MiCo BioMed Co., Ltd. cancelled the acquisition of Siloam Biosciences, Inc from a group of shareholders.	24/05/19	CI
MiCo BioMed Co., Ltd. agreed to acquire 98.3% stake in Siloam Biosciences, Inc from a group of shareholders for KRW 5.1 billion.	24/05/18	CI
MiCo BioMed Co., Ltd. announced that it has received KRW 5 billion in funding	22/05/18	CI
Sunkyu Jeon acquired an additional 4.2% stake in MiCo BioMed Co., Ltd. from Sungwoo Kim for KRW 2.9 billion.	17/05/18	CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 5 billion in funding	14/05/18	CI
Nanobiosys Inc. completed the acquisition of Micobiomed Co., Ltd. from MiCo Ltd., Sun-Kyu Jeon, Byungseung Kang and others.	16/11/17	CI
MiCo NanoBioSys Co., Ltd.'s Equity Buyback announced on August 31, 2017 has expired.	30/10/17	CI
Nanobiosys Inc. announces an Equity Buyback.	31/08/17	CI
Nanobiosys Inc. authorizes a Buyback Plan.	30/08/17	CI
Nanobiosys Inc. signed a merger contract to acquire Micobiomed Co., Ltd. from MiCo Ltd., Sun-Kyu Jeon, Byungseung Kang and others for KRW 35.3 billion.	30/08/17	CI
MiCo BioMed Co., Ltd. announced that it has received KRW 3.5497125 billion in funding	28/04/16	CI

MiCo BioMed Co Ltd, formerly MiCo NanoBioSys Co Ltd, is a Korea-based company mainly engaged in developing in vitro diagnostic (IVD) medical equipments and devices. The Company operates its business through three segments. The Molecular Diagnosis segment mainly manufactures and sells products such as nucleic acid extraction equipment, gene amplification equipment, reagents, and lab chips. The Biochemical Diagnosis segment mainly manufactures and supplies products such as complex diagnostics, anemia meters, blood glucose meters, medical devices and strips. The Immunodiagnostic Business segment mainly produces and sells immunodiagnostic devices and immunodiagnostic kits.

Sector

Advanced Medical Equipment & Technology

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
MICO BIOMED CO., LTD.	-25.11%	43.44M
SARTORIUS AG	-27.52%	16.28B
QUIDELORTHO CORPORATION	-40.04%	2.96B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+15.16%	1.79B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-6.86%	1.52B
BIOTAGE AB	+38.67%	1.33B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-15.36%	968M
REVENIO GROUP OYJ	+3.53%	840M
CONTEC MEDICAL SYSTEMS CO.,LTD	-26.08%	833M
CELLAVISION AB	+23.58%	630M